PT - JOURNAL ARTICLE AU - Savannah J. Hoyt AU - Jessica M. Storer AU - Gabrielle A. Hartley AU - Patrick G. S. Grady AU - Ariel Gershman AU - Leonardo G. de Lima AU - Charles Limouse AU - Reza Halabian AU - Luke Wojenski AU - Matias Rodriguez AU - Nicolas Altemose AU - Leighton J. Core AU - Jennifer L. Gerton AU - Wojciech Makalowski AU - Daniel Olson AU - Jeb Rosen AU - Arian F. A. Smit AU - Aaron F. Straight AU - Mitchell R. Vollger AU - Travis J. Wheeler AU - Michael C. Schatz AU - Evan E. Eichler AU - Adam M. Phillippy AU - Winston Timp AU - Karen H. Miga AU - Rachel J. O’Neill TI - From telomere to telomere: the transcriptional and epigenetic state of human repeat elements AID - 10.1101/2021.07.12.451456 DP - 2021 Jan 01 TA - bioRxiv PG - 2021.07.12.451456 4099 - http://biorxiv.org/content/early/2021/07/12/2021.07.12.451456.short 4100 - http://biorxiv.org/content/early/2021/07/12/2021.07.12.451456.full AB - Mobile elements and highly repetitive genomic regions are potent sources of lineage-specific genomic innovation and fingerprint individual genomes. Comprehensive analyses of large, composite or arrayed repeat elements and those found in more complex regions of the genome require a complete, linear genome assembly. Here we present the first de novo repeat discovery and annotation of a complete human reference genome, T2T-CHM13v1.0. We identified novel satellite arrays, expanded the catalog of variants and families for known repeats and mobile elements, characterized new classes of complex, composite repeats, and provided comprehensive annotations of retroelement transduction events. Utilizing PRO-seq to detect nascent transcription and nanopore sequencing to delineate CpG methylation profiles, we defined the structure of transcriptionally active retroelements in humans, including for the first time those found in centromeres. Together, these data provide expanded insight into the diversity, distribution and evolution of repetitive regions that have shaped the human genome.Competing Interest StatementKHM has received travel funds to speak at symposia organized by Oxford Nanopore. WT has two patents (8,748,091 and 8,394,584) licensed to Oxford Nanopore Technologies. All other authors declare that they have no competing interests.